This puts Genentec as owner of tecentric(Atezolizumab) in competition with Merck for IMU in a trial sense.
Merck being involved in keytruda combo trial.
Two HUGE Pharmas heavily invested in reviewing our IMU drugs.
I know we are all waiting but this is great news for cancer sufferers and means all majors are interested in what LC and team have put together.
I am a believer so I think its just amazing that a small company in essentially 6 years (since first trial of Hervaxx) has created so much value.
I dont think they have wasted a dollar of shareholders funds.
Lets hope the share price reflects this value I perceive soon.
GLTA shareholder
Why IMU is a multi multi bagger, page-12797
-
- There are more pages in this discussion • 12,055 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.002(3.45%) |
Mkt cap ! $409.9M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.6¢ | $1.124M | 19.72M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 933589 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 776750 | 4 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |